- Added the Tier 1 Strategy to the EUTF non-Medicare retiree plans, which allows pharmacies to dispense select brand products when the cost for the brand is less than the generic. Member pays the generic copay or the cost of the drug, whichever is less.
- Added prior authorization requirements for anti-diabetic GLP-1 (e.g. Ozempic, Rybelsus, Trulicity, Victoza) and GIP/GLP-1 agonists agents (e.g., Mounjaro) to the EUTF non-Medicare retiree plans.
- Added quantity limits for anti-platelet products under the EUTF non-Medicare retiree plans effective October 1, 2023. Existing members using anti-platelet products will be grandfathered and will not be subject to these quantity limits.
CVS/SSI Retiree Benefits
What’s New?
Effective July 1, 2023 (unless otherwise specified):
For EUTF Members
| CVS/SSI Plan | January 1 - December 31, 2024 | January 1 - December 31, 2023 |
|---|---|---|
| EUTF SSI Prescription Drug Plan (Medicare) | Summary of Benefits Evidence of Coverage | Summary of Benefits Evidence of Coverage |
| EUTF CVS Prescription Drug Plan (Non-Medicare) | Benefits at a Glance | Benefits at a Glance |
For HSTA VB Members
| CVS/SSI Plan | January 1 - December 31, 2024 | January 1 - December 31, 2023 |
|---|---|---|
| HSTA VB SSI Prescription Drug Plan (Medicare) | Summary of Benefits Evidence of Coverage | Summary of Benefits Evidence of Coverage |
| HSTA VB CVS Prescription Drug Plan (Non-Medicare) | Benefits at a Glance | Benefits at a Glance |